Cargando…

Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve

AIMS: The overall aim was to identify sub‐clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety‐one patients with CKD stages 3 and 4, without a diagnosis of heart disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashioulis, Pavlos, Guron, Cecilia Wallentin, Svensson, Maria K., Hammarsten, Ola, Saeed, Aso, Guron, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524098/
https://www.ncbi.nlm.nih.gov/pubmed/32648666
http://dx.doi.org/10.1002/ehf2.12878
_version_ 1783588489071165440
author Kashioulis, Pavlos
Guron, Cecilia Wallentin
Svensson, Maria K.
Hammarsten, Ola
Saeed, Aso
Guron, Gregor
author_facet Kashioulis, Pavlos
Guron, Cecilia Wallentin
Svensson, Maria K.
Hammarsten, Ola
Saeed, Aso
Guron, Gregor
author_sort Kashioulis, Pavlos
collection PubMed
description AIMS: The overall aim was to identify sub‐clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety‐one patients with CKD stages 3 and 4, without a diagnosis of heart disease, and 41 healthy matched controls were included in this cross‐sectional study. Cardiac morphology and function were analysed with Doppler echocardiography and coronary flow velocity reserve (CFVR) in response to adenosine was measured in the left anterior descendent artery to detect coronary microvascular dysfunction (CMD). All study subjects had a left ventricular (LV) ejection fraction > 50%. Patients with CKD showed statistically significant increases in left atrial volume index and transmitral and pulmonary vein flow velocities during atrial contraction and prolonged LV isovolumetric relaxation time. Patients with CKD had significantly reduced CFVR vs. controls (2.74 ± 0.86 vs. 3.40 ± 0.89, P < 0.001), and 43% of patients were classified as having CMD compared with 9% of controls (P = 0.001). CONCLUSIONS: Patients with CKD stages 3 and 4, without a diagnosis of heart disease, showed early abnormalities in LV diastolic function that did not fulfil the criteria for LV dysfunction according to current guidelines. A large proportion of CKD patients had CMD, suggesting that microvascular abnormalities may have a pathogenic role in the development of heart failure in this patient group.
format Online
Article
Text
id pubmed-7524098
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75240982020-10-02 Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve Kashioulis, Pavlos Guron, Cecilia Wallentin Svensson, Maria K. Hammarsten, Ola Saeed, Aso Guron, Gregor ESC Heart Fail Original Research Articles AIMS: The overall aim was to identify sub‐clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety‐one patients with CKD stages 3 and 4, without a diagnosis of heart disease, and 41 healthy matched controls were included in this cross‐sectional study. Cardiac morphology and function were analysed with Doppler echocardiography and coronary flow velocity reserve (CFVR) in response to adenosine was measured in the left anterior descendent artery to detect coronary microvascular dysfunction (CMD). All study subjects had a left ventricular (LV) ejection fraction > 50%. Patients with CKD showed statistically significant increases in left atrial volume index and transmitral and pulmonary vein flow velocities during atrial contraction and prolonged LV isovolumetric relaxation time. Patients with CKD had significantly reduced CFVR vs. controls (2.74 ± 0.86 vs. 3.40 ± 0.89, P < 0.001), and 43% of patients were classified as having CMD compared with 9% of controls (P = 0.001). CONCLUSIONS: Patients with CKD stages 3 and 4, without a diagnosis of heart disease, showed early abnormalities in LV diastolic function that did not fulfil the criteria for LV dysfunction according to current guidelines. A large proportion of CKD patients had CMD, suggesting that microvascular abnormalities may have a pathogenic role in the development of heart failure in this patient group. John Wiley and Sons Inc. 2020-07-10 /pmc/articles/PMC7524098/ /pubmed/32648666 http://dx.doi.org/10.1002/ehf2.12878 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Kashioulis, Pavlos
Guron, Cecilia Wallentin
Svensson, Maria K.
Hammarsten, Ola
Saeed, Aso
Guron, Gregor
Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title_full Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title_fullStr Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title_full_unstemmed Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title_short Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
title_sort patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524098/
https://www.ncbi.nlm.nih.gov/pubmed/32648666
http://dx.doi.org/10.1002/ehf2.12878
work_keys_str_mv AT kashioulispavlos patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve
AT guronceciliawallentin patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve
AT svenssonmariak patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve
AT hammarstenola patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve
AT saeedaso patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve
AT gurongregor patientswithmoderatechronickidneydiseasewithoutheartdiseasehavereducedcoronaryflowvelocityreserve